APOE and dementia: In addition, although our ratios of APOE and MAPT carriers are consistent with the natural frequency of these genes in non-selected population, the unbalanced groups defined by genetic risks may also impede the generalization of our conclusions to other data sets where genetic risks are enriched by including patients with dementia.